Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Proton Pump Inhibitors


AddThis Social Bookmark Button

Proton Pump Inhibitors Linked To Fractures Lawsuits

Proton Pump Inhibitors | Lawsuits, Lawyers | Side Effects: Fractures, Hip Fractures, Spine Fractures, Wrist Fractures | Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex

Have you experienced a fracture while taking Nexium, Prilosec, Prevacid? These heart burn drugs, known as proton pump inhibitors (PPIs), have been linked to an increased risk of fractures of the hip, wrist, and spine. In May 2010, the U.S. Food & Drug Administration (FDA) announced that it was revising the safety labels for both prescription and over-the-counter PPIs to reflect this risk.

Each year doctors write about 113.4 million prescriptions for PPIs to treat conditions like gastroesophageal reflux disease (GERD), stomach ulcers and other disorders. Even more people rely on over-the-counter (OTC) PPIs to deal with heart burn and stomach issues.  Our PPI fracture lawyers believe thousands of people may have suffered broken bones as a result of these popular medications. Yet most victims of PPI-related fractures probably have no idea that the drugs played a role in their injury.

If you broke your hip, wrist or spine while taking one of these medications, our PPI fracture lawyers want to hear from you. You may be entitled to compensation for your medical bills, lost wages, and pain and suffering. We urge you to contact us right away to protect your legal rights.

FDA Warning

PPIs work by reducing the amount of acid in the stomach. Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex, and Vimovo are available by prescription to treat conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus. Prilosec OTC, Zegerid OTC, and Prevacid 24HR are sold over-the-counter for the treatment of frequent heartburn.

For patients with chronic heart burn and other stomach problems, PPIs are a godsend. Unfortunately, long-term use of PPIs can come with a price. Several recent scientific studies found that people, especially women over 50, were more likely to suffer fractures, especially of the wrists, spine and hips, if they've also taken PPIs longer than a year.

According to an FDA Drug Safety Communication published in May 2010, these PPI studies used claims data from computerized administrative databases to evaluate the risk of fractures of the hip, wrist, and spine in patients treated with PPIs compared to individuals who were not using PPIs. The studies were generally six months in duration.

According to the FDA Drug Safety Communication, six studies reported an increased risk of fractures with the use of PPIs. Exposure to PPIs ranged from a period of 1 to 12 years, depending on the study. The emergence of fractures varied among studies; with one study reporting an increase in fractures with use of PPIs in the previous year and another study finding an increase after 5 to 7 years of PPI use.

The increased risk of fractures seen in the studies was primarily observed in older individuals. Two studies reported an increase in fractures with higher doses of PPI, and two studies reported an increase in fractures with longer duration of use.

According to the FDA, only one study did not find a relationship between PPI use and fractures. This study limited the subject population to those without major risk factors for fracture.

Following a review of these studies, the FDA decided to revise the Warnings and Precautions section of the prescription labeling as well as the OTC Drug Facts label for PPIs. The FDA has advised that health care professionals and consumers should weigh the known benefits against the potential risks of PPIs when determining if these medications are appropriate for treatment. Consumers also should talk with their health care professional about any concerns.

It is important that people using OTC versions of the medications read and follow the directions on the OTC Drug Facts label. According to the FDA, such PPIs should only be used as directed for 14 days for the treatment of frequent heartburn. No more than three 14-day treatment courses should be used in one year. If your heartburn continues, talk to your healthcare professional.

Legal Help for Victims of PPI Fractures

We offer a free case evaluation to victims of possible PPI-related fractures. If you or a loved one took a prescription PPI such as Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex, or Vimovo, we urge you to contact us today.

We also offer free consultations to fracture victims who took OTC versions of these drugs, including Prilosec OTC, Zegerid OTC, and Prevacid 24HR. Please fill out our online form, or call 1 800 LAW INFO (1-800-529-4636) to discuss your case with one of our PPI fracture lawyers today.

Proton Pump InhibitorsRSS Feed

Older Women Face Hip Fracture Risk from PPIs

Feb 1, 2012 | Parker Waichman Alonso LLP
Post-menopausal women, especially if they smoke, might want to think twice about taking a proton pump inhibitor (PPI) to relieve heartburn.  According to a new study in the British Medical Journal (BMJ), post-menopausal women who take PPIs like Nexium, Prilosec and Prevacid for two years or more increase their risk of sustaining a hip fracture by 35 percent.The study also found that women who took the PPIs for six to eight years were 50 percent more likely to suffer a broken hip....

Plavix, Proton Pump Inhibitor Warnings Revised in Canada

Sep 23, 2011 | Parker Waichman LLP
Health Canada is revising the label for Plavix in that country to reflect new information about the concurrent use of the blood thinner and other drugs called proton pump inhibitors (PPIs).   Many Plavix users take PPIs to counteract the ulcers and heartburn that can accompany use of the blood thinner.In 2009, Health Canada updated the labels for ALL PPIs to recommend they not be used with Plavix, after some research indicated that the drugs could reduce the efficacy of Plavix. ...

Proton Pump Inhibitors Can Impact Magnesium Levels, Study Finds

Jul 12, 2011 | Parker Waichman LLP
A new study is backing up the U.S. Food & Drug Administration's (FDA) recent decision to issue a warning about low  magnesium levels and proton pump inhibitors.   The study, which was reported at the annual Digestive Disease Week conference in May, found that used of the popular heartburn drugs  was associated with an increased risk of hypomagnesemia occurrence, which remained significant after adjustment for all confounders.Hypomagnesemia - low serum magnesium levels...

Hip Fracture Risk Higher in Older Women on Proton Pump Inhibitors

Jun 8, 2011 | Parker Waichman LLP
A study presented last month at the annual Digestive Disease Week in Chicago has confirmed that long-term use of proton pump inhibitors, such as Nexium, increases the risk of hip fractures in post-menopausal women.  According to Internal Medicine News, the study also found that the hip fracture risk  was higher among women who used the popular heart burn drugs, even when adjusting for other risk factors including vitamin D intake; history of osteoporosis; and use of hormone...

Proton Pump Inhibitors May Reduce Benefits of Aspirin Therapy

Jun 7, 2011 | Parker Waichman LLP
Taking a proton pump inhibitor like Nexium is probably not a good option for heart attack patients being treated with aspirin.  A new study published in the British Medical Journal has found that the addition of a proton pump inhibitor places these aspirin therapy patients in greater danger of experiencing a serious, possibly fatal, cardiovascular event.The authors of the article, researchers from Copenhagen University in Denmark, called for further studies in this area to the drug...

More Proton Pump Inhibitors News